|
|
|
Management | Associates | Board | Partners
.jpg) |
Baiju R. Shah,
President & CEO
Baiju R. Shah is President and CEO and a Founder of BioEnterprise. He focuses on BioEnterprise's strategic initiatives as well as counseling clients on business and financial matters. Prior to BioEnterprise, Shah was with McKinsey & Company, where he played a leading role in the Growth and Business Building practice. In the community, Shah serves on Boards of The Saint Luke’s Foundation, Great Lakes Science Center, Yale Alumni Association, NorTech, TiE Ohio, and Summer on the Cuyahoga, and also the Governor’s Third Frontier Biomedical Advisory Board, Workforce Policy Board, and Strategic Development Advisory Boards. Shah received a J.D. from Harvard and his B.A. from Yale.
Click to download photo
Click to download short biography
Click to download full biography
|
 |
Robert Baxter,
Vice President
Bob Baxter leads strategic planning, alliances, and administrative operations. He has spent more than 30 years in the private sector, most recently as Vice President of the Regulatory Studies business unit of Ricerca, a contract drug development company. In this position, he was responsible for the pre-clinical testing necessary for FDA IND/NDA submittals. Baxter received a M.S. degree in Chemical Engineering from Ohio State University and a B.S. degree in Chemical Engineering from the University of Detroit.
Click to download photo
|
 |
Annette Ballou,
Director, Strategic Marketing & Communications
Annette Ballou leads strategic marketing for BioEnterprise, helping the initiative and its companies in market positioning, message definition, and communication strategy. Ballou has over 20 years of experience in health care marketing and business development in a range of private companies. She has expertise in strategic planning and implementation, business development, marketing, communications and operations, Ballou received her J.D. from Southern Methodist University as well as a B.A. in English and a B.S. in Psychology.
Click to download photo
|
 |
Carol Clark,
Vice President
Carol Clark leads the company’s effort for advising growth stage health care opportunities including acquisition-based strategies approaches. Clark brings 20 years of experience in structuring and syndicating complex leveraged buyouts, acquisition financings and business expansion facilities at the Bank of Boston and Aetna Life & Casualty. Recently she was involved as a founding officer and Board member in the creation of NineSigma, a Cleveland-based technology start-up. She served as the company's CFO and was a key member of the private equity fund raising team. Currently she serves on the Industry Advisory Board for the Cornell Center for Technology Enterprise and Commercialization. Clark, a CFA, received an M.B.A. from Cornell University and B.A. from Wesleyan University.
Click to download photo
|
 |
Glen Gaughan, Ph.D,
CEO-in-Residence
Glen Gaughan focuses on developing and supporting biopharmaceutical companies for BioEnterprise. He works closely with a number of the companies, supporting the development of their business strategies and operating plans. Gaughan has almost 20 years of experience as a drug discovery scientist with Bristol-Myers Squibb. In roles ranging from Principal Investigator to Group Leader, he contributed to programs searching for new medications for pain, obesity, sleep disorders, and depression, and for contrast agents for MRI. Gaughan designed ProHance, an MRI contrast agent marketed by Bracco. Gaughan holds a Ph.D. in Chemistry from the University of Oregon, an MBA from Case Western Reserves, and a B.A. from Dartmouth.
Click to download photo
|
 |
Margaret E. Groh, Ph.D.,
Director, Business Development
Meg Groh focuses on business development for biopharmaceutical companies and also oversees the due diligence process for new opportunities. She has extensive research experience at the Jefferson Institute of Molecular Medicine, Howard Hughes Medical Institute, the University of Chicago and Case Western Reserve University. Her work covered several areas of molecular medicine including lipid metabolism, molecular cardiology, and stem cell biology. Groh received a Ph.D. from the University of Chicago, a B.S. from Tulane University and an M.B.A. from Case Weatherhead School of Management.
Click to download photo
|
 |
Bob Johnson,
Vice President
Bob Johnson is a leader of the medical devices team at BioEnterprise. He has an extensive background in the medical device industry across many functions including new ventures, marketing and business development. Johnson has commercialized devices, instrumentation, and diagnostic technologies for cardiology, radiology, obstetrics/gynecology, pulmonology and urology applications. In addition, he has completed numerous transactions including financings, acquisitions, licenses and strategic alliances in his work. Throughout his career, Mr. Johnson has worked in executive capacities for medical device companies including C.R. Bard, Respironics, and Mallinckrodt. Johnson has a B.S. in Business Administration from Loyola University in Baltimore, Maryland.
Click to download photo
|
Photo
Coming
Soon |
R.K. Khosla,
CEO-in-Residence
R.K. Khosla is a serial technology entrepreneur who was most recently the CEO of Peritec Biosciences, a Cleveland Clinic medical device spinout. Khosla has a wide background in finance, entrepreneurship and venture capital. Highlights include two years as a Principal concentrating on wireless technologies at Crystal Ventures, a tech venture fund with $240 million under management with offices in Cleveland, Palo Alto, Singapore & Taipei. He was also CFO and Director of Back Office Operations for All Wound Up which was sold to Borders Group. Khosla started his career at National City in Corporate Banking with the majority of his time being spent in Merchant Banking and Mergers & Acquisitions. Khosla received a BS in Electrical Engineering and Applied Physics with an Economics Minor from Case Western Reserve University and his MBA from Yale.
|
 |
Susan Luria,
Vice President
Susan Luria leads the company's efforts to attract and develop medical imaging companies in the region. Her background includes managing operations, mergers, acquisitions, expansion activities and divestitures in both venture-financed and publicly traded health care service companies. Prior to BioEnterprise, Luria worked with Team NEO, a regional economic development organization where she led efforts to successfully attract a number of large businesses, including some biomedical companies, to establish and expand their operations in Northeast Ohio. Those efforts required partnering businesses with potential customers, suppliers, service providers and various forms of governmental support. Luria received an M.B.A. from Case Western Reserve and a B.A. from Dartmouth.
Click to download photo
|
 |
Bill Poore,
Vice President
Bill Poore manages finance and administration functions for both BioEnterprise and BioOhio. The functions include financial projections and statements, grants managements, accounting, personnel administration, and general operations. He brings over 30 years of experience in these areas to BioEnterprise. Poore holds both an MBA in Finance and a BBA in Accounting from Cleveland State University.
Click to download photo
|
 |
Denise Richardson,
Director, Business Development
Denise Richardson serves as a Director of Business Development, supporting BioEnterprise's strategic initiatives, recruitment of biomedical companies to the region, and the development of a network of resources to support health care company growth. Her corporate experience includes managing the Microbiology laboratory for Mogul Corporation, then a division of Dexter Corp. She was also the Vice President of Regulatory Affairs for United States Biochemical (USB) and Director of Regulatory Affairs for Amersham Pharmacia Biotech. Richardson has worked in research laboratories at the University of California, Santa Barbara (UCSB), Harvard University Medical School, and Eli Lilly. Richardson received her B.S. degree in Microbiology, with highest distinction, from Purdue University, and her M.S. in Marine Biology from Boston University.
Click to download photo
|
 |
Chris Sklarin
Director, Business Development
Chris Sklarin focuses on health care service and software companies. He brings over 20 years of experience in product development, sales engineering, and technology investing, having worked in development roles in several software startups as well as the last six years in seed investing and venture capital. Most recently he covered the Upper Midwest for Chrysalis Ventures, an early and growth-stage investor in the healthcare and technology sectors, establishing their Cleveland office. While there, he oversaw over $22 million in investment in new and follow-on transactions, including companies in the healthcare services and healthcare informatics sectors. Prior to Chrysalis, he worked for JumpStart, Inc. as an Investment Associate where he specialized in early stage investment analysis and participated in investing over $6 million in 17 companies. Sklarin has a BS in Electrical Engineering from the Massachusetts Institute of Technology and an MBA from the Haas School of Business, University of California at Berkeley.
Click to download photo
|
 |
Karen Spilizewski,
Vice President
Karen Spilizewski is a leader of BioEnterprise's medical device team and is also a Vice President with RiverVest Ventures. She brings nearly 20 years of experience in new product development and business development in medical and non-medical technologies. Spilizewski worked as a business development manager at Avery Dennison and in product development roles ranging from research manager to associate. She was responsible for conducting marketing, financial, technical, and competitive analyses of new opportunities for microelectronic, biomedical, optical display, and MEMs applications. In product development roles, she has developed and commercialized products for various medical devices, including wound care, diagnostics, surgical, and electromedical applications. Spilizewski received her MBA, M.S. in Macromolecular Science and a B.S. degree in Biomedical Engineering from Case Western Reserve.
Click to download photo
|
 |
Laurie Toth,
Marketing Manager
Laurie Toth is the marketing manager at BioEnterprise. In this capacity she performs industry market research, produces the quarterly electronic newsletter, facilitates events and conferences and manages the website and IT systems. Ms. Toth received her BA in Business Administration from Baldwin-Wallace College in Berea, Ohio.
Click to download photo
|
 |
Ray Ursick,
Chief Regulatory Officer in Residence
Raymond E. Ursick has been a Regulatory Affairs and Quality Systems professional for over 25 years. He has obtained FDA approvals for diagnostic imaging devices, cardiovascular devices and implants, sterilization and other infection control devices, surgical devices, electronic pain management and therapy devices, and critical care monitoring equipment. Additionally, he has led successful programs to achieve ISO 9001/EN46001, ISO 13485 certification, to obtain CE Marking, and to achieve Quality Awards using Malcolm Baldridge criteria. Ursick has held executive positions at three Johnson & Johnson operating companies (Technicare, Critikon, and Interventional Systems) and at STERIS as Vice President, Regulatory Affairs and Quality Systems.
Click to download photo
|
 |
Jim Weisman,
Vice President
Jim Weisman leads BioEnterprise’s efforts in serving and developing start-up health care software and service opportunities. He brings almost 20 years of experience in general management, having worked in senior management at PepsiCo and Macy’s as well as consulting to major financial institutions while with the First Manhattan Consulting Group. Weisman served on the management team of HealthSync, a start-up company developing marketplaces for defined-contribution based corporate sponsored health insurance. He has worked with Glengary Ventures, a fund focused on technology based companies, and provided consulting and executive management services to early-stage companies in the biotech and satellite communications industries. Weisman received his B.S. in Economics from The Wharton School at the University of Pennsylvania and his Executive MBA from Case Weatherhead School of Management.
Click to download photo
|
|
|
|